Beran M - Search Results

1

Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.

Keating MJ, Estey E, Kantarjian H, Plunkett W, O'Brien S, Koller C, Beran M, Freireich EJ. Keating MJ, et al. Among authors: beran m. Leukemia. 1992;6 Suppl 2:78-80. Leukemia. 1992. PMID: 1578950 Review. No abstract available.

2

Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome.

Lin CW, Manshouri T, Jilani I, Neuberg D, Patel K, Kantarjian H, Andreeff M, Estrov Z, Beran M, Keating M, Estey E, Albitar M. Lin CW, et al. Among authors: beran m. Leuk Res. 2002 Jun;26(6):551-9. doi: 10.1016/s0145-2126(01)00170-9. Leuk Res. 2002. PMID: 12007503

3

A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia.

Giles FJ, Cortes JE, Kantarjian HM, O'Brien SM, Estey E, Beran M. Giles FJ, et al. Among authors: beran m. Leuk Res. 2004 Apr;28(4):353-7. doi: 10.1016/j.leukres.2003.08.013. Leuk Res. 2004. PMID: 15109534 Clinical Trial.

4

FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype.

Beran M, Luthra R, Kantarjian H, Estey E. Beran M, et al. Leuk Res. 2004 Jun;28(6):547-50. doi: 10.1016/j.leukres.2003.09.016. Leuk Res. 2004. PMID: 15120929

5

Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.

Kantarjian H, Beran M, Cortes J, O'Brien S, Giles F, Pierce S, Shan J, Plunkett W, Keating M, Estey E. Kantarjian H, et al. Among authors: beran m. Cancer. 2006 Mar 1;106(5):1099-109. doi: 10.1002/cncr.21699. Cancer. 2006. PMID: 16435387 Free article.

6

Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse.

Ravandi F, Kantarjian H, Faderl S, Garcia-Manero G, O'Brien S, Koller C, Pierce S, Brandt M, Kennedy D, Cortes J, Beran M. Ravandi F, et al. Among authors: beran m. Leuk Res. 2010 Jun;34(6):752-6. doi: 10.1016/j.leukres.2009.10.001. Epub 2009 Oct 29. Leuk Res. 2010. PMID: 19878996 Free PMC article.

7

Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon.

Beran M, Andersson B, Kantarjian H, Keating M, Rios A, McCredie KB, Freireich EJ, Gutterman J. Beran M, et al. Leukemia. 1987 Jan;1(1):52-7. Leukemia. 1987. PMID: 2444829

8

Response to salvage therapy and survival after relapse in acute myelogenous leukemia.

Keating MJ, Kantarjian H, Smith TL, Estey E, Walters R, Andersson B, Beran M, McCredie KB, Freireich EJ. Keating MJ, et al. Among authors: beran m. J Clin Oncol. 1989 Aug;7(8):1071-80. doi: 10.1200/JCO.1989.7.8.1071. J Clin Oncol. 1989. PMID: 2666590

9

Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside.

Kantarjian HM, Walters RS, Keating MJ, Talpaz M, Andersson B, Beran M, McCredie KB, Freireich EJ. Kantarjian HM, et al. Among authors: beran m. Cancer. 1988 Aug 15;62(4):672-6. doi: 10.1002/1097-0142(19880815)62:4<672::aid-cncr2820620404>3.0.co;2-t. Cancer. 1988. PMID: 3165046

10

Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemia.

Walters RS, Kantarjian HM, Keating MJ, Plunkett WK, Estey EH, Andersson B, Beran M, McCredie KB, Freireich EJ. Walters RS, et al. Among authors: beran m. Cancer. 1988 Aug 15;62(4):677-82. doi: 10.1002/1097-0142(19880815)62:4<677::aid-cncr2820620405>3.0.co;2-b. Cancer. 1988. PMID: 3165047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters